Get an alert when PFIZER LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Cash

—

Latest balance sheet

Net assets

£984m

-34.4% vs 2024

Employees

1,154

-7.2% lowest in 3 filed years

Profit before tax

£49m

-91.2% lowest in 3 filed years

Accounts

3-year trend · Δ = latest vs prior filed period · latest reflected 2025-11-30

Metric Trend 2023-11-302024-11-302025-11-30 Δ vs prior
Turnover £1,158,133,000£552,829,000£576,260,000 +4.2%
Operating profit £75,740,000£34,986,000£7,103,000 -79.7%
Profit before tax £168,483,000£554,263,000£48,559,000 -91.2%
Net profit £133,044,000£551,149,000£31,687,000 -94.3%
Cash ——— —
Total assets less current liabilities £865,055,000—— —
Net assets £899,964,000£1,500,370,000£983,988,000 -34.4%
Equity £899,964,000£1,500,370,000£983,988,000 -34.4%
Average employees 1,2441,2431,154 -7.2%
Wages £64,682,000£90,618,000£57,083,000 -37%
Directors' remuneration £1,866,000£1,866,000£2,428,000 +30.1%
Highest paid director £469,658£481,799£583,692 +21.1%

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-11-302024-11-302025-11-30
Operating margin 6.5%6.3%1.2%
Net margin 11.5%99.7%5.5%
Return on capital employed 8.8%——
Gearing (liabilities / total assets) 36.1%26.5%12.5%
Current ratio 2.33x3.96x3.94x
Interest cover ——22.84x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
FRS 102
Reporting scope
Standalone (parent only)
Auditor
KPMG LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The directors have prepared the financial statements on the going concern basis as they do not intend to liquidate the Company or to cease its operations, and as they have concluded that the Company’s financial position means that this is realistic. They have also concluded that there are no material uncertainties that could have cast significant doubt over its ability to continue as a going concern for at least a year from the date of approval of the financial statements ('the going concern period').”

Group structure

  1. PFIZER LIMITED · parent
    1. John Wyeth & Brother Ltd 100% · UK
    2. Wyeth Pharmaceuticals Limited 100% · UK
    3. PZR Ltd 100% · UK
    4. PZR Property Limited 100% · UK
    5. Hospira UK Limited 100% · UK
    6. Global Blood Therapeutics UK Limited 100% · UK
    7. Seagen UK Limited 100% · UK

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

7 active · 85 resigned

Name Role Appointed Born Nationality
HIGHTON, David Ian Director 2022-06-23 Jul 1968 British
MCGINLEY, John, Dr Director 2024-10-11 Dec 1976 Irish
NIJHER, Gurjinder Monica Kaur, Dr Director 2026-04-09 Jan 1977 British
PATTENDEN, Adam Edward Director 2025-04-23 Oct 1975 British
PEARSON, Edwin James Director 2017-01-09 Jan 1974 British
PHILLIPS, Berkeley Simon, Dr Director 2012-10-26 Jul 1969 British
SAINSBURY, Sarah Louise Director 2024-05-01 Aug 1971 British
Show 85 resigned officers
Name Role Appointed Resigned
HORTON, David Jeremy Secretary — 1995-12-15
MOUNT, Jacqueline Ann Secretary 2012-02-01 2021-01-21
SUMNER, Matthew James Secretary 2004-02-06 2012-01-13
THOMAS, Robert Hugh, Dr Secretary 1996-11-15 2004-02-06
ZANANIRI, Francis Anthony Secretary 1995-12-15 1996-10-11
ALDENHOVEN, Clive Paul Director — 1992-09-30
AUDLEY, Tony George Robert Director 1994-12-01 2004-05-31
BAUMAN, Eric Director 2005-04-28 2006-02-02
BENTLEY, Timothy Director 1994-12-01 2001-05-31
BEVAN, David Gower Director 2009-04-20 2013-04-19
BLACKBURN, Richard Neville Director 2009-02-09 2012-01-01
BRANDICOURT, Olivier Raymond Director 2003-04-30 2007-02-01
BROWNING, Richard Charles Director 1997-06-27 1999-04-08
CALDINI, Peter Director 2015-02-25 2016-05-15
CAMPBELL, Simon Fraser, Dr Director 1996-12-20 1998-09-30
COE, Peter Charles Director 1995-04-03 2001-11-30
COLES, Ruth Amy Director 2011-04-13 2015-07-24
CROW, Richard John Director — 1996-10-22
DAY, Robert Michael Director 2015-04-22 2016-07-19
DAY, Robert Michael Director 2009-04-20 2012-10-11
DOHERTY, Annette Marian Director 2011-07-15 2012-07-31
DOHERTY, Annette Marian Director 2003-08-08 2009-03-26
DOLAN, Thomas Francis Director 2012-10-26 2016-12-31
DOOGAN, Declan Patrick, Dr Director 2001-05-01 2003-08-05
DOOGAN, Declan Patrick, Dr Director 1991-12-20 1995-03-17
DUNCAN, Greg Director 1997-07-01 1999-04-08
DUNNING, Anthony Alister Director — 1998-04-30
EATON, James Andrew Director 2005-10-27 2008-01-15
ECCLES, Stella Director 2002-08-16 2006-07-31
EDWARDS, Geoffrey Mansel Director 1993-07-01 1997-03-13
EMBLING, John Clyde Director 2008-01-10 2010-03-08
EMMS, Jonathan Charles Director 2012-01-01 2015-01-31
FAUERBACH, Michael Director 2006-04-20 2009-02-28
FLETCHER, Karolyn Director 2000-02-07 2009-02-12
FLETCHER, Karolyn Director 1998-05-01 1999-04-08
FRANKLIN, Ian Eric Director 2008-11-01 2021-02-09
GILL, Imogen Director 2010-03-05 2012-11-06
GREENFIELD, Elizabeth Mary Director 2012-10-26 2018-04-30
HALL, Michael Christopher Director — 1999-04-08
HANLEY, John Martin Director 2010-03-05 2013-04-16
HARNETT, Denise Jean Director 2018-04-26 2024-05-01
HUGHES, Darius Bruce Director 2014-02-05 2016-07-19
JOHNSON, Carole Anne Director 2016-02-12 2017-03-17
JONES, Maurice Ernest Director — 2002-06-30
KNIGHT, Susan Pernille Director 2012-02-01 2012-05-03
LISSAMAN, John Director — 1994-11-25
MARSHALL, George Arthur Director 1993-12-01 1996-01-28
MARSHALL, Vaila Mackenzie Director 2002-08-07 2003-06-06
MASTIN, Charles Norman Director — 1993-10-05
MCDOWALL, Ewan John Director 2013-07-04 2014-02-07
MCGIBNEY, David, Doctor Director 1996-12-20 2001-03-01
MCKERNAN, Ruth Mitchell Director 2010-09-17 2015-04-10
MORAN, Kenneth James Director 1996-03-22 1999-12-31
MOUNT, Jacqueline Ann Director 2021-01-21 2022-05-31
NORDKAMP, Hendrikus Hermannus Director 2015-02-25 2020-11-16
NOSEWORTHY, Darren Director 2015-07-24 2017-01-09
O'CONNOR, William Hugh Director — 1996-03-22
OSBORN, Ben Director 2018-11-05 2022-04-29
OSBORN, Benjamin John Director 2012-10-26 2015-04-22
OVERTOOM, Franciscus Johannes Carolus Director 2004-04-22 2008-11-01
PACKARD, Robert Spencer Director — 1991-12-31
POULTON, Steven Michael Director 2009-04-20 2013-01-07
REYNOLDS, David Stuart, Dr Director 2015-04-22 2016-03-03
RICHARDSON, Scott Director 2017-02-09 2018-03-14
RIENOW, Susan Director 2022-02-28 2024-10-08
RIENOW, Susan Director 2018-03-23 2019-02-05
RINGROSE, Peter Stuart, Dr Director 1992-12-18 1996-11-25
ROBINSON, Ivar Director 2000-02-07 2002-02-05
ROBLIN, David, Dr Director 2009-02-09 2010-08-09
ROSE, Paul Richard Director 2019-02-06 2020-04-26
SELLER, Colin Malcolm Director 2017-04-27 2019-09-23
SELLER, Colin Malcolm Director 2006-08-01 2016-02-12
SMITH, John Richard Director 2012-02-01 2015-02-25
SMITH, Roger Llewellyn Director 2019-10-10 2025-04-24
STONE, Roger Director 2002-05-20 2005-09-20
THOMPSON, Julian Keith, Dr Director 2016-12-31 2025-02-21
TIIVOLA, Timo Rolf Juhani Director 2001-06-29 2002-12-20
TULLY, Paula Director 2013-02-07 2017-02-16
WALLCRAFT, Susan Jean Director 2009-02-09 2011-04-06
WHITEHEAD, Anthony Martin, Dr Director 1995-04-03 1999-04-08
WICKS, Stephen Richard Director 2009-02-09 2010-03-31
WILSON, Alan Brian Director — 1992-11-09
WILSON, Michael John Director 1993-07-01 1999-04-07
WILSON, William John Director — 1995-04-03
YOUNG, John Douglas Director 2007-02-07 2009-04-17

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Pfizer Inc Corporate entity Shares 75–100%, Voting 75–100% 2017-04-06 Active

Filing timeline

Last 20 of 317 total filings

Date Type Category Description
2026-08-17 AA accounts Accounts with accounts type full
2026-07-09 CS01 confirmation-statement Confirmation statement with no updates PDF
2026-04-22 AP01 officers Appoint person director company with name date PDF
2025-08-29 AA accounts Accounts with accounts type full
2025-07-07 CS01 confirmation-statement Confirmation statement with updates PDF
2025-05-08 AP01 officers Appoint person director company with name date PDF
2025-04-24 TM01 officers Termination director company with name termination date PDF
2025-02-24 TM01 officers Termination director company with name termination date PDF
2024-10-14 AP01 officers Appoint person director company with name date PDF
2024-10-08 TM01 officers Termination director company with name termination date PDF
2024-08-29 AA accounts Accounts with accounts type full
2024-07-10 CS01 confirmation-statement Confirmation statement with updates PDF
2024-05-10 AP01 officers Appoint person director company with name date PDF
2024-05-09 TM01 officers Termination director company with name termination date PDF
2024-05-03 SH01 capital Capital allotment shares PDF
2023-08-22 AA accounts Accounts with accounts type full
2023-07-11 CS01 confirmation-statement Confirmation statement with updates PDF
2022-08-09 AA accounts Accounts with accounts type full
2022-07-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-06-23 AP01 officers Appoint person director company with name date PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
3

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
0

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page